id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-263874-q0egnzwf	Khan, Md. Arif	Comparative molecular investigation of the potential inhibitors against SARS-CoV-2 main protease: a molecular docking study	2020-07-22		.txt	text/plain	2991	166	52	Assessing evidences from molecular docking studies, it was clearly seen that, Epirubicin, Vapreotida, and Saquinavir exhibited better binding affinity against SARS-CoV-2 Main Protease than other drug molecules among the 23 potential inhibitors. Also, researchers have currently reported using the drug repurposing approach based on the molecular docking and dynamics study where the key target proteins are 3CL protease, RNA dependent RNA polymerase (RdRp), and spike proteins (Elfiky, 2020b; Muralidharan et al., 2020; Smith & Smith, 2020; Tahir Ul Qamar et al., 2020; Yu et al., 2020) . In this ground, it is clearly seen that Epirubicin, Vapreotida, and Saquinavir may inhibit COVID-19 by synergistic interactions among the 23 potential inhibitors against SARS-CoV-19 main protease and those results pave the way in drug discovery although it has to be further validated by in vitro and in vivo investigations.	./cache/cord-263874-q0egnzwf.txt	./txt/cord-263874-q0egnzwf.txt